Welcome to our dedicated page for 1933 Inds news (Ticker: TGIFF), a resource for investors and traders seeking the latest updates and insights on 1933 Inds stock.
1933 Industries Inc. (TGIFF) operates as a vertically integrated cannabis enterprise, producing premium flower, pre-rolls, and extracts under its AMA and Level X brands. This page aggregates official press releases and verified news about the company’s Nevada operations, product innovations, and market strategies.
Investors and industry observers will find timely updates on earnings reports, cultivation facility upgrades, and regulatory developments. The curated collection serves as a reliable resource for tracking the company’s responses to evolving cannabis market conditions and competitive pressures.
Content spans operational milestones, wholesale partnership announcements, and product line changes – including historical context on the suspended Canna Hemp™ CBD business. All materials maintain factual accuracy focus without speculative commentary.
Bookmark this page for streamlined access to 1933 Industries’ latest communications. Check regularly for updates reflecting the company’s position in Nevada’s dynamic cannabis sector.
1933 Industries Inc. (CSE:TGIF)(OTCQB:TGIFF) announced its Q2 2023 financial results for the period ending January 31, 2023. The company reported $3.6 million in revenue, a 13% increase from Q2 2022, and a total of $9.2 million for the first half of the fiscal year, up 52% year-over-year. Expenses significantly decreased by 92% to $0.2 million due to a tax refund. Despite a net loss of $0.4 million, the company achieved positive Adjusted EBITDA of $0.1 million for the second consecutive quarter. Cash reserves improved to $2.9 million from $0.8 million in the prior year. Ester Vigil was appointed as President, enhancing leadership.
1933 Industries Inc. (CSE:TGIF)(OTCQB:TGIFF) reported its Q1 2023 financial results, achieving record revenues of $5.64 million, a 129% increase year-over-year. The gross margin reached $2.0 million, while the company posted an adjusted EBITDA of $0.1 million. Despite a net loss of $1.2 million, management highlights a disciplined cost strategy and ongoing demand for AMA branded products. The results underscore the company's growth trajectory in the cannabis sector, despite facing pressure from competitive pricing.